Shares of Clovis Oncology Inc. (NASDAQ: CLVS) catapulted about 120% by afternoon trade. The biopharmaceutical Company reported on Monday that its early stage clinical trials on a lung cancer treatment showed contraction in the size of tumor. The experimental treatment, dubbed as CO-1686, targets to cure non-small lung cancer (NSCLC) in patients with a transmutation in gene T790M.
Continue reading Major Movers on June 3; CLVS, TSRO, MNKD, CBRL, FFIV
Shares of Qualcomm Inc. (NASDAQ: QCOM) plunged about 5.50% in early trade after the semiconductor company, late last evening, provided lower-than-expected guidance on fiscal third quarter earnings although its outlook on revenue exceeded Wall Street’s expectation. For the fiscal second quarter, Qualcomm posted adjusted earnings of $1.17 a share, in-line with analysts’ expectation. Revenue stood at $6.12 billion, beating analysts’ consensus estimate of $6.09 billion.
Continue reading Major Movers on April 25; QCOM, AKAM, ZNGA, FFIV, DOW, CAKE
Orix Corporation (ADR) (NYSE: IX) rallied on Wednesday. The Tokyo based financial services provider and Funabashi Eco Services Corporation announced in February that will merge to form a new entity referred to as Orix Eco Services Corporation. The merge is aimed at creating synergies and improving customer services.
Continue reading Major Movers on April 6; IX, JCP, WLL-A, FFIV, HBI, NIHD